Telehealth startup Cerebral halts controlled substance prescriptions

Telehealth startup Cerebral halts controlled substance prescriptions

Mental health startup Cerebral will no longer prescribe most controlled substances, The Wall Street Journal reported. The embattled company is facing investigations from the US Department of Justice and the Drug Enforcement Administration over its prescribing practices, which, until this week, included offering prescriptions for stimulants like Adderall. Company co-founder Kyle Robertson wrote in an…

Continue reading
SIDS study shows the risks of science hype

SIDS study shows the risks of science hype

Sudden infant death syndrome, or SIDS, is a devastating condition that’s still very poorly understood, so when new research comes out, it can feel like a very big deal — especially if that research seems to offer a way to save children’s lives. Posts on social media cheered one such new study this week, heralding…

Continue reading